BCAB vs KEY · $5.9M cap vs P/E 13, rev $7.51B
Bioatla Inc (BCAB) versus KeyCorp (KEY) — a side-by-side from cached financials, not a winner call.
Bioatla Inc (BCAB) is a biotechnology company listed on NASDAQ.
KeyCorp (KEY) is a banks - regional company listed on US.
Latest reported BCAB revenue for 2023-09-30 was $0. Net income was -$33.3M. BCAB currently screens at market cap $5.9M.
Latest reported KEY revenue for 2025-12-31 was $7.51B. Net income was $1.83B. Revenue was up 62.7% from 2024-12-31 to 2025-12-31. KEY currently screens at market cap $22.64B and trailing P/E 12.8.
BCAB currently screens at market cap $5.9M. KEY currently screens at market cap $22.64B and trailing P/E 12.8.
Not investment advice. Open the BCAB and KEY stock pages for the full models.
Not investment advice.